Quick Answer
Xenon Pharmaceuticals Inc. reported Total Revenue of $311.0 thousand for fiscal year 2017.
Xenon Pharmaceuticals Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2017 | $311.0K | -82.8% |
| 2016 | $1.80M | -88.4% |
| 2015 | $15.58M | -45.1% |
| 2014 | $28.37M | +3.7% |
| 2013 | $27.36M | +91.2% |
| 2012 | $14.31M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2017 | $264.0K | -36.1% | +1660.0% |
| June 30, 2017 | $15.0K | -96.4% | -6.2% |
| March 31, 2017 | $16.0K | -97.3% | -96.1% |
| September 30, 2016 | $413.0K | -90.4% | +0.0% |
| June 30, 2016 | $413.0K | -89.8% | -31.3% |
| March 31, 2016 | $601.0K | -85.0% | -86.0% |
| September 30, 2015 | $4.29M | -67.5% | +6.1% |
| June 30, 2015 | $4.05M | -23.6% | +0.9% |
- Xenon Pharmaceuticals Inc. showed a decrease of -82.8% in Total Revenue compared to the prior fiscal year.
- Over the 2012–2017 period, Xenon Pharmaceuticals Inc.’s total revenue has declined by 97.8% (from $14.31 million to $311.0 thousand).
- The most recent figure is from Xenon Pharmaceuticals Inc.’s fiscal year 2017 report (Form 10-K), filed with the SEC on March 7, 2018.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: